Information Provided By:
Fly News Breaks for July 31, 2019
Jul 31, 2019 | 04:59 EDT
Mizuho analyst Ann Hynes views the 9% post-earnings selloff yesterday in shares of HCA Healthcare as an overreaction. Expectations were high for a beat and a meaningful guidance raise going into the Q2 report given the significant outperformance in Q1, and HCA did not meet those expectations, Hynes tells investors in a research note. The analyst, however, does not believe there is any fundamental change to HCA's business. She keeps a Buy rating on the shares with a $153 price target.